Hyperlipasemia and Potential Pancreatic Injury Patterns in COVID-19: A Marker of Severity or Innocent Bystander?

Goyal, Hemant; Sachdeva, Sonali; Perisetti, Abhilash; Mann, Rupinder; Inamdar, Sumant; Tharian, Benjamin

Goyal, Hemant; Sachdeva, Sonali; Perisetti, Abhilash; Mann, Rupinder; Inamdar, Sumant; Tharian, Benjamin.

Goyal H; The Wright Center for Graduate Medical Education, Scranton, Pennsylvania; Mercer University School of Medicine, Macon, Georgia. Electronic address: doc.hemant@yahoo.com.
Sachdeva S; Department of Cardiology, Boston Medical Center, Boston, Massachusetts.
Perisetti A; Department of Gastroenterology and Hepatology, The University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Mann R; Department of Internal Medicine, Saint Agnes Medical Center, Fresno, California.
Inamdar S; University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Tharian B; University of Arkansas for Medical Sciences, Little Rock, Arkansas.

Gastroenterology ; 160(3): 946-948.e2, 2021 02.

Article in English | MEDLINE | ID: covidwho-894433

Subject(s)

COVID-19/epidemiology; Lipase/blood; Pancreatic Diseases/epidemiology; Biomarkers/blood; COVID-19/diagnosis; Clinical Enzyme Tests; Humans; Pancreatic Diseases/blood; Pancreatic Diseases/diagnosis; Predictive Value of Tests; Prevalence; Prognosis; Risk Assessment; Risk Factors; Severity of Illness Index; Up-Regulation

Keywords

COVID-19; Clinical Outcome; Hyperlipasemia; Lipase; Pancreatitis; SARS-CoV-2; Severity

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pancreatic Diseases / COVID-19 / Lipase Type of study: Diagnostic study / Observational study / Prognostic study / Reviews Limits: Humans Language: English Journal: Gastroenterology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google